Start-Up Spotlight: Exo Hopes To Democratize Ultrasound With Handheld Device
Exo has raised $100m to support the development and commercialization of its “pMUT” portable ultrasound imaging system and software that makes ultrasound images easier to interpret.
You may also be interested in...
Butterfly Network is disseminating the lessons from China and Italy about the poential value of lung ultrasound in the management of COVID-19 patients with respiratory disease.
Market Intel: Precision Diagnostics And Focal Treatments Offer Personalized Approach To Prostate Cancer
The combined market for prostate cancer diagnostics and minimally invasive treatments is set to increase from $900m to $1.46bn in the next five years. But conservative treatment, or watchful waiting, is popular, limiting growth of newer, focal treatments.
The company is running a pilot program to allow glioblastoma patients who use Novocure’s Optune Tumor Treating Fields device to download data from the device at home.